Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
30346 | 170 | 40.0 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
57 | 3 | ANGIOTENSIN II//HYPERTENSION//PERIPHERAL VASCULAR DISEASES | 89232 |
85 | 2 | ANGIOTENSIN II//RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN | 27105 |
30346 | 1 | AT1A MRNA//ABCB4 KNOCKOUT//ANGIOTENSIN ANG 1 7 | 170 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | AT1A MRNA | authKW | 359241 | 1% | 100% | 2 |
2 | ABCB4 KNOCKOUT | authKW | 179621 | 1% | 100% | 1 |
3 | ANGIOTENSIN ANG 1 7 | authKW | 179621 | 1% | 100% | 1 |
4 | ANGIOTENSIN BLOCKING AGENTS | authKW | 179621 | 1% | 100% | 1 |
5 | ANGIOTENSIN I CONVERTING ENZYME PEPTIDYL DIPEPTIDASE A | authKW | 179621 | 1% | 100% | 1 |
6 | ANGIOTENSIN II INHIBITOR | authKW | 179621 | 1% | 100% | 1 |
7 | ANGIOTENSIN II TYPE 1A KNOCKOUT MOUSE | authKW | 179621 | 1% | 100% | 1 |
8 | ANGOTENSINOGEN AGT | authKW | 179621 | 1% | 100% | 1 |
9 | AT1R BLOCKER | authKW | 179621 | 1% | 100% | 1 |
10 | CATHEDRA PHYSIOPATHOL | address | 179621 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 3066 | 41% | 0% | 69 |
2 | Medicine, Research & Experimental | 159 | 12% | 0% | 21 |
3 | Physiology | 90 | 9% | 0% | 15 |
4 | Pharmacology & Pharmacy | 49 | 12% | 0% | 21 |
5 | Peripheral Vascular Diseases | 31 | 5% | 0% | 8 |
6 | Endocrinology & Metabolism | 19 | 5% | 0% | 9 |
7 | Pathology | 17 | 4% | 0% | 6 |
8 | Medical Laboratory Technology | 14 | 2% | 0% | 3 |
9 | Toxicology | 9 | 3% | 0% | 5 |
10 | Cardiac & Cardiovascular System | 8 | 4% | 0% | 7 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CATHEDRA PHYSIOPATHOL | 179621 | 1% | 100% | 1 |
2 | CLIN MALALTIES DIGEST METAB INVEST BIOMED | 179621 | 1% | 100% | 1 |
3 | CLIN POLICLIN TRANSPLANT MED | 179621 | 1% | 100% | 1 |
4 | GERNOTOL | 179621 | 1% | 100% | 1 |
5 | HOSP JOSE M PENNA | 179621 | 1% | 100% | 1 |
6 | LIUHUA BRIDGE HOSP | 179621 | 1% | 100% | 1 |
7 | MALATIES DIGEST METABOLLIVER UNIT | 179621 | 1% | 100% | 1 |
8 | MED KLIN WERPUNKT HEPATOL GASTROENETROL | 179621 | 1% | 100% | 1 |
9 | QUIM FISCIOQUIM BIOL | 179621 | 1% | 100% | 1 |
10 | THER Y ENDOCRINOL | 179621 | 1% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEPATOLOGY RESEARCH | 5458 | 5% | 0% | 9 |
2 | LIVER INTERNATIONAL | 2543 | 4% | 0% | 6 |
3 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 1835 | 2% | 0% | 3 |
4 | JOURNAL OF GASTROENTEROLOGY | 1822 | 4% | 0% | 6 |
5 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 1602 | 4% | 0% | 7 |
6 | JOURNAL OF HEPATOLOGY | 1153 | 4% | 0% | 7 |
7 | AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY | 1029 | 4% | 0% | 6 |
8 | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 973 | 4% | 0% | 6 |
9 | DIGESTIVE DISEASES AND SCIENCES | 893 | 5% | 0% | 8 |
10 | IRANIAN JOURNAL OF IMMUNOLOGY | 807 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ZHU, QQ , LI, N , LI, F , ZHOU, ZH , HAN, QY , LV, Y , SANG, J , LIU, ZW , (2016) THERAPEUTIC EFFECT OF RENIN ANGIOTENSIN SYSTEM INHIBITORS ON LIVER FIBROSIS.JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. VOL. 17. ISSUE 1. P. - | 25 | 46% | 0 |
2 | ABBAS, G , SILVEIRA, MG , LINDOR, KD , (2011) HEPATIC FIBROSIS AND THE RENIN-ANGIOTENSIN SYSTEM.AMERICAN JOURNAL OF THERAPEUTICS. VOL. 18. ISSUE 6. P. E202-E208 | 25 | 49% | 9 |
3 | GOH, GB , PAGADALA, MR , DASARATHY, J , UNALP-ARIDA, A , SARGENT, R , HAWKINS, C , SOURIANARAYANANE, A , KHIYAMI, A , YERIAN, L , PAI, R , ET AL (2015) RENIN-ANGIOTENSIN SYSTEM AND FIBROSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE.LIVER INTERNATIONAL. VOL. 35. ISSUE 3. P. 979 -985 | 19 | 42% | 13 |
4 | MUNSHI, MK , UDDIN, MN , GLASER, SS , (2011) THE ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN LIVER FIBROSIS.EXPERIMENTAL BIOLOGY AND MEDICINE. VOL. 236. ISSUE 5. P. 557 -566 | 30 | 31% | 28 |
5 | ZHU, R , YANG, L , SHEN, L , YE, J , LIU, JG , HU, SJ , (2009) ANG II-AT(1) RECEPTOR PATHWAY IS INVOLVED IN THE ANTI-FIBROTIC EFFECT OF BETA-ELEMENE.JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES. VOL. 29. ISSUE 2. P. 177 -181 | 13 | 72% | 5 |
6 | COREY, KE , SHAH, N , MISDRAJI, J , ABU DAYYEH, BK , ZHENG, H , BHAN, AK , CHUNG, RT , (2009) THE EFFECT OF ANGIOTENSIN-BLOCKING AGENTS ON LIVER FIBROSIS IN PATIENTS WITH HEPATITIS C.LIVER INTERNATIONAL. VOL. 29. ISSUE 5. P. 748 -753 | 15 | 58% | 32 |
7 | ABU DAYYEH, BK , YANG, M , DIENSTAG, JL , CHUNG, RT , (2011) THE EFFECTS OF ANGIOTENSIN BLOCKING AGENTS ON THE PROGRESSION OF LIVER FIBROSIS IN THE HALT-C TRIAL COHORT.DIGESTIVE DISEASES AND SCIENCES. VOL. 56. ISSUE 2. P. 564-568 | 12 | 67% | 27 |
8 | WARNER, FJ , LUBEL, JS , MCCAUGHAN, GW , ANGUS, PW , (2007) LIVER FIBROSIS: A BALANCE OF ACES?.CLINICAL SCIENCE. VOL. 113. ISSUE 3-4. P. 109-118 | 26 | 30% | 50 |
9 | GUILLAUD, O , GURRAM, KC , PUGLIA, M , LILLY, L , ADEYI, O , RENNER, EL , SELZNER, N , (2013) ANGIOTENSIN BLOCKADE DOES NOT AFFECT FIBROSIS PROGRESSION IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION.TRANSPLANTATION PROCEEDINGS. VOL. 45. ISSUE 6. P. 2331-2336 | 14 | 42% | 4 |
10 | JUN, L , HAO, G , ZHONG-TAO, Z , YU, W , (2008) EFFECT OF ANGIOTENSIN II AND ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST ON THE PROLIFERATION, CONTRACTION AND COLLAGEN SYNTHESIS IN RAT HEPATIC STELLATE CELLS.CHINESE MEDICAL JOURNAL. VOL. 121. ISSUE 2. P. 161 -165 | 9 | 75% | 0 |
Classes with closest relation at Level 1 |